
Join to View Full Profile
3205 S Russell StMissoula, MT 59801
Phone+1 406-721-4906
Fax+1 406-447-7916
Are you Dr. D'Amico?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anthony D'Amico, MD is a board certified radiologist in Missoula, Montana. He is currently licensed to practice medicine in Montana, Washington, and Arizona. He is a Professor of Radiation Oncology at Brigham and Women's Hospital.
Education & Training
- University of MichiganFellowship, Neuroradiology, 2007 - 2008
- University of MichiganResidency, Radiology-Diagnostic, 2003 - 2007
- University of WashingtonInternship, Internal Medicine, 2002 - 2003
- University of Washington School of MedicineClass of 2002
Certifications & Licensure
- MT State Medical License 2007 - 2025
- WA State Medical License 2017 - 2025
- AZ State Medical License 2007 - 2010
- OH State Medical License 2007 - 2009
- TN State Medical License 2007 - 2009
- IL State Medical License 2007 - 2008
- KY State Medical License 2007 - 2008
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsReply to G. Francolini et al.Anthony V. D'Amico, Wanling Xie, Philip W. Kantoff
Journal of Clinical Oncology. 2021-09-17 - 32 citationsRadiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Pr...Jonathan E. Leeman, Yu-Hui Chen, Paul J. Catalano, Jeremy S. Bredfeldt, Martin T. King
International Journal of Radiation Oncology, Biology, Physics. 2021-08-16 - 2 citationsProstate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk p...Danielle S. Bitterman, Ming-Hui Chen, Jing Wu, Andrew A. Renshaw, Marian Loffredo
Cancer. 2021-08-01
Press Mentions
- New Findings Could Change Treatment Practice and Lengthen Survival for Men with pN1 Prostate CancerMarch 15th, 2022
- Anthony D'Amico, MD, on Docetaxel in Men with Unfavorable-Risk Prostate CancerNovember 3rd, 2021
- Anthony D'Amico, MD, PhD, on Adjuvant vs Early Salvage RTSeptember 22nd, 2021
- Join now to see all